Cryogenic Preservation and Treatment Systems for Biological Samples, Organs, Vaccines, Cancer Cells, and Food Products

The present inventive concept expands the core technology of the original integrated cold therapy-compression therapy assembly to entirely new industries and applications, including cryogenic preservation of biological samples, organs, vaccines, cancer cells, and food products.

The original patent focused on medical devices for applying cold therapy and compression therapy to patients. However, the limitations of the original patent did not consider the vast potential of cryogenic preservation and treatment in various industries. The present inventive concept addresses this gap by leveraging the core technology to develop innovative solutions for cryogenic preservation and treatment of biological samples, organs, vaccines, cancer cells, and food products.

The inventive concept comprises a system for cryogenic preservation of biological samples, organs, vaccines, cancer cells, and food products, utilizing an integrated cold therapy-compression therapy assembly. The assembly includes a coolant reservoir containing a cryogenic fluid, a treatment pad or storage compartment designed to maintain a temperature below -80°C, and a control unit regulating the temperature and pressure of the cryogenic fluid. The system enables long-term preservation of biological samples, organs, vaccines, and food products, and facilitates cryogenic treatment of cancer cells.

The new claims introduce novel applications and use cases for the core technology, expanding its scope beyond medical devices. The inventive step lies in the adaptation of the integrated cold therapy-compression therapy assembly to cryogenic preservation and treatment of biological samples, organs, vaccines, cancer cells, and food products, addressing unmet needs in these industries.

Alternative embodiments may include modular designs for different industries, customized treatment pads or storage compartments for specific applications, and variations in cryogenic fluid composition or temperature control mechanisms. These variations ensure broad conceptual coverage and adaptability to diverse industry requirements.

The inventive concept has significant commercial potential in industries such as biotechnology, organ transplantation, vaccine development, cancer research, and food processing. The market demand for effective cryogenic preservation and treatment solutions is substantial, and the present inventive concept is poised to capture a significant share of this market.